JUBLPHARMA

Jubilant Pharmova Ltd.

NSE: JUBLPHARMA

BSE: 530019

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

997.75+47.4 (+4.99%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

71.9 / 100

Value Score

50.9 / 100

Price Momentum Score

63.7 / 100

QVM Score

73.3 / 100

Key Metrics

Market Cap

15804.10

P/E (TTM)

44.89

P/B

2.23

P/S (TTM)

1.84

EV/EBITDA

14.72

CAPE (5Y)

50.64

ROE (TTM)

5.97

ROCE (TTM)

8.33

ROA (TTM)

2.82

Avg 3Y ROE

7.25

Earnings 3Y CAGR

Sales 3Y CAGR

10.29

Sales 5Y CAGR

3.18

Debt/Equity

0.51

Consensus TP

1242.50

Strong Buy %

25.00

Promoter Holding

47.68

Pledged %

6.58

Stock Analysis

Fundamental analysis overview of Jubilant Pharmova Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 16.27% for 12-month ended 30 Jun 2026 and the growth was 5.68 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 16.27

-99.6111701.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.51 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.07 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 73.6 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

73.6 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 44.89 indicates that the stock is expensive on a standalone basis and is at a 41.25% premium to industry median P/E

What is P/E Ratio?

Median: 31.78

Value 44.89

-0.96721.13

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -6.92% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low and declining ROE

The company reported low ROE of 5.97% for 12-month ended 30 Jun 2026 and ROE declined by -839 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of 8.7% for 12-month ended 30 Jun 2026 and operating margin declined by -258 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -23.43% for 12-month ended 30 Jun 2026 and the growth was 30.63 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.5%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Jubilant Pharmova Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Jubilant Pharmova Ltd. Shareholding Pattern

Quarterly breakdown of Jubilant Pharmova Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	50.68	47.68	47.68	47.68	47.68	47.68
Indian Promoter	46.51	46.51	46.51	46.51	46.51	46.51	46.51	46.51	46.51	46.51	47.39	47.39	47.39	47.39	47.39	47.39	47.39	47.39	47.39	47.39	47.39	44.39	44.39	44.39	44.39	44.39
Foreign Promoter	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29
Institutions	29.78	28.53	27.18	26.75	26.97	26.57	24.17	24.24	24.08	24.09	24.66	25.00	26.08	24.83	24.84	23.18	22.83	23.56	23.60	23.93	24.26	26.92	27.09	27.18	27.52	28.27
Mutual Funds / UTI	1.36	1.15	0.77	0.57	0.78	1.15	0.36	0.39	0.05	0.04	0.39	0.40	0.40	0.41	0.42	1.50	2.27	2.25	3.06	3.64	3.66	6.01	7.13	7.69	8.03	8.99
FI/Bank/Insurance	0.12	0.12	0.00	0.00	0.00	0.00	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.64	1.41	1.36	1.15	1.13	1.13	1.13	1.13
Govt	-	-	-	-	-	-	-	-	-	-	-	-	1.24	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	27.91	26.96	26.05	25.73	25.69	24.82	23.14	23.18	23.45	23.47	23.06	23.38	23.22	23.20	23.20	20.29	19.06	19.50	17.94	16.96	17.23	17.40	16.56	15.96	15.90	15.87
Other Institutions	0.40	0.31	0.35	0.46	0.50	0.60	0.63	0.63	0.58	0.58	1.21	1.22	1.22	1.22	1.22	1.39	1.50	1.81	1.96	1.93	2.02	2.36	2.27	2.41	2.47	2.28
Non-Institution	19.54	20.79	22.15	22.57	22.36	22.75	25.16	25.08	25.25	25.24	24.67	24.33	23.24	24.50	24.48	26.14	26.49	25.77	25.73	25.39	25.06	25.40	25.24	25.14	24.80	24.05
Bodies Corporate	3.26	3.69	3.51	3.99	3.73	3.06	3.18	3.26	2.72	2.72	2.85	2.71	2.95	2.99	3.00	3.67	3.96	4.09	3.60	3.16	3.28	3.42	3.24	3.31	3.26	3.12
Others (incl. Retail) No. of shareholders	16.28 47,619	17.10 59,208	18.64 74,145	18.58 64,151	18.63 61,283	19.69 86,749	21.98 1,12,915	21.82 1,08,568	22.53 1,07,269	22.52 1,08,627	21.82 1,04,971	21.62 99,554	20.29 97,281	21.51 92,736	21.48 88,749	22.47 85,939	22.53 91,582	21.68 81,206	22.13 88,609	22.23 1,01,487	21.78 95,578	21.98 98,639	22.00 92,354	21.83 89,168	21.54 85,414	20.93 81,812

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Smallcap 250	0.35%	102 / 249
2	Nifty 500	0.04%	324 / 499
3	Nifty Total Market	0.04%	364 / 749

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Jubilant Pharmova Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Jubilant Employees Welfare Trust Trust	October-2025	Market Purchase (Acquisition) 1st Oct 2025	0.63 %	₹ 1,076.73	11.32 k	₹ 1.22 cr
Jubilant Employees Welfare Trust Trust	September-2025	Market Purchase (Acquisition) 30th Sep 2025	0.55 %	₹ 1,069.66	50.68 k	₹ 5.42 cr
Jubilant Employees Welfare Trust Trust	September-2025	Market Purchase (Acquisition) 30th Sep 2025	0.58 %	₹ 1,039.25	20.00 k	₹ 2.08 cr
Jubilant Employees Welfare Trust Trust	September-2025	Market Purchase (Acquisition) 30th Sep 2025	0.60 %	₹ 1,056.37	57.18 k	₹ 6.04 cr
Jubilant Employees Welfare Trust Trust	September-2025	Market Purchase (Acquisition) 24th Sep 2025	0.53 %	₹ 1,107.83	35.00 k	₹ 3.88 cr
SPB Trustee Company Private Limited and SS Trustee Company Private Limited Promoter Group	June-2025	Block Deal (Disposal) 16th Jun 2025	20.52 %	₹ 1,060.00	7.00 lac	₹ 74.20 cr
Jubilant Enpro Private Limited Promoter Group	June-2025	Block Deal (Disposal) 16th Jun 2025	1.33 %	₹ 1,060.00	21.16 lac	₹ 224.30 cr
Nikita Resources Private Limited Promoter Group	June-2025	Block Deal (Disposal) 16th Jun 2025	2.20 %	₹ 1,060.37	19.62 lac	₹ 208.09 cr
Jubilant Employees Welfare Trust Trust	September-2024	Market Purchase (Acquisition) 20th Sep 2024	0.55 %	₹ 1,214.32	10.03 k	₹ 1.22 cr
Jubilant Employees Welfare Trust Trust	September-2024	Market Purchase (Acquisition) 20th Sep 2024	0.53 %	₹ 1,215.45	36.02 k	₹ 4.38 cr

…

Corporate Actions

History of Jubilant Pharmova Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 5/share
Record date: 24th Jul 2026Ex-date: 24th Jul 2026
Announced on: 22nd May 2026
Dividend₹ 5/share
Record date: 25th Jul 2025Ex-date: 25th Jul 2025
Announced on: 16th May 2025
Dividend₹ 5/share
Record date: 2nd Aug 2024Ex-date: 2nd Aug 2024
Announced on: 29th May 2024
Dividend₹ 5/share
Record date: 10th Aug 2023Ex-date: 10th Aug 2023
Announced on: 29th May 2023
Dividend₹ 5/share
Record date: 12th Aug 2022Ex-date: 11th Aug 2022
Announced on: 27th May 2022

Company Profile

Overview of Jubilant Pharmova Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Propriet...

Key personnel

Mr. Ashish Mukkirwar

Chief Financial Officer

Mr. Naresh Kapoor

Compliance Officer, Company Secretary

Mr. Hari Shanker BhartiaD

Non-Executive Co-Chairman of the Board

Mr. Shyam Sunder BhartiaD

Non-Executive Chairman of the Board

Mr. Arjun Shanker BhartiaD

Joint Managing Director, Executive Director

Shri. Priyavrat BhartiaD

Managing Director, Executive Director

Mr. Shirish Gundopant BelapureD

Non-Executive Independent Director

Dr. Harsh MahajanD

Non-Executive Independent Director

View all

Incorporated on

21 Jun 1978

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

5,657

IPO date

09 Nov 1994

Free Float

6,13,95,799

Website

https://www.jubl.com/

Phone no.

+911204361000

Address

1A, Sector 16A, NOIDA, 201301, India

Frequently Asked Questions

What is the current share price of Jubilant Pharmova Ltd.?

The current share price of Jubilant Pharmova Ltd. is ₹ 997.75 as of 8 Sep 2026.

What is the market capitalisation of Jubilant Pharmova Ltd.?

The market capitalisation of Jubilant Pharmova Ltd. stands at ₹ 15,804.10 Cr.

What is the PE ratio of Jubilant Pharmova Ltd.?

The Price-to-Earnings (PE) ratio of Jubilant Pharmova Ltd. is 44.89 as of the latest trailing twelve months data.

What is the ROE and ROCE of Jubilant Pharmova Ltd.?

Jubilant Pharmova Ltd. has a Return on Equity (ROE) of 5.97% and a Return on Capital Employed (ROCE) of 8.33% as per the latest financial reports.

What is the 52-week high and low of Jubilant Pharmova Ltd.?

The 52-week high of Jubilant Pharmova Ltd. is - and the 52-week low is -.

What is the dividend yield of Jubilant Pharmova Ltd.?

The dividend yield of Jubilant Pharmova Ltd. is 0.50% based on the current market price.

What is the FII and DII holding in Jubilant Pharmova Ltd.?

Foreign Institutional Investors (FII) hold 15.87%, Domestic Institutional Investors (DII) hold 10.12% and retail/public investors hold 20.93% of Jubilant Pharmova Ltd. shares.

What sector does Jubilant Pharmova Ltd. belong to?

Jubilant Pharmova Ltd. operates in the Healthcare sector. 75% of analysts have a Buy or Strong Buy rating on Jubilant Pharmova Ltd. with a consensus target price of ₹ 1,242.50, implying 24.53% upside from current levels.

What is the beta of Jubilant Pharmova Ltd.?

The beta of Jubilant Pharmova Ltd. is 0.64, indicating its price volatility relative to the broader market. Over the past 1 year, Jubilant Pharmova Ltd. has delivered an absolute return of -3.97%.

What is the RSI of Jubilant Pharmova Ltd.?

The 14-day Relative Strength Index (RSI) of Jubilant Pharmova Ltd. is 70.48, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Jubilant Pharmova Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Jubilant Pharmova Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile

Holdings and Presence